Cargando…
Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards. Endocrine disrupting substances c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215718/ https://www.ncbi.nlm.nih.gov/pubmed/27862884 http://dx.doi.org/10.1002/ieam.1866 |
_version_ | 1783710295860969472 |
---|---|
author | Parrott, Joanne L Bjerregaard, Poul Brugger, Kristin E Gray, L Earl Iguchi, Taisen Kadlec, Sarah M Weltje, Lennart Wheeler, James R |
author_facet | Parrott, Joanne L Bjerregaard, Poul Brugger, Kristin E Gray, L Earl Iguchi, Taisen Kadlec, Sarah M Weltje, Lennart Wheeler, James R |
author_sort | Parrott, Joanne L |
collection | PubMed |
description | Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards. Endocrine disrupting substances can have specific and profound effects when exposure occurs during sensitive windows of the life cycle (development, reproduction). This creates the potential for delayed effects that manifest when exposure has ceased, possibly in a different life stage. This potential underscores the need for testing in appropriate (sensitive) life stages and full life cycle designs. Such tests are available in the Organisation for Economic Co-operation and Development (OECD) tool box and should be used to derive endpoints that can be considered protective of all life stages. Similarly, the potential for effects to be manifest in subsequent generations (multigenerational effects) has also been raised as a potential issue in the derivation of appropriate endpoints for EDS. However, multigenerational studies showing increasing sensitivity of successive generations are uncommon. Indeed this is reflected in the design of new higher tier tests to assess endocrine active substances (EAS) that move to extended one-generation designs and away from multi-generational studies. The occurrence of NMDRs is also considered a limiting factor for reliable risk assessment of EDS. Evidence to date indicates NMDRs are more prevalent in in vitro and mechanistic data, not often translating to adverse apical endpoints that would be used in risk assessment. A series of steps to evaluate NMDRs in the context of endocrine hazard and risk assessment procedures is presented. If careful consideration of delayed, multigenerational effects and NMDRs is made, it is feasible to assess environmental endocrine hazards and derive robust apical endpoints for risk assessment procedures ensuring a high level of environmental protection. |
format | Online Article Text |
id | pubmed-8215718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-82157182021-06-21 Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances Parrott, Joanne L Bjerregaard, Poul Brugger, Kristin E Gray, L Earl Iguchi, Taisen Kadlec, Sarah M Weltje, Lennart Wheeler, James R Integr Environ Assess Manag Article Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards. Endocrine disrupting substances can have specific and profound effects when exposure occurs during sensitive windows of the life cycle (development, reproduction). This creates the potential for delayed effects that manifest when exposure has ceased, possibly in a different life stage. This potential underscores the need for testing in appropriate (sensitive) life stages and full life cycle designs. Such tests are available in the Organisation for Economic Co-operation and Development (OECD) tool box and should be used to derive endpoints that can be considered protective of all life stages. Similarly, the potential for effects to be manifest in subsequent generations (multigenerational effects) has also been raised as a potential issue in the derivation of appropriate endpoints for EDS. However, multigenerational studies showing increasing sensitivity of successive generations are uncommon. Indeed this is reflected in the design of new higher tier tests to assess endocrine active substances (EAS) that move to extended one-generation designs and away from multi-generational studies. The occurrence of NMDRs is also considered a limiting factor for reliable risk assessment of EDS. Evidence to date indicates NMDRs are more prevalent in in vitro and mechanistic data, not often translating to adverse apical endpoints that would be used in risk assessment. A series of steps to evaluate NMDRs in the context of endocrine hazard and risk assessment procedures is presented. If careful consideration of delayed, multigenerational effects and NMDRs is made, it is feasible to assess environmental endocrine hazards and derive robust apical endpoints for risk assessment procedures ensuring a high level of environmental protection. 2017-01-18 2017-03 /pmc/articles/PMC8215718/ /pubmed/27862884 http://dx.doi.org/10.1002/ieam.1866 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Article Parrott, Joanne L Bjerregaard, Poul Brugger, Kristin E Gray, L Earl Iguchi, Taisen Kadlec, Sarah M Weltje, Lennart Wheeler, James R Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances |
title | Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances |
title_full | Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances |
title_fullStr | Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances |
title_full_unstemmed | Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances |
title_short | Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances |
title_sort | uncertainties in biological responses that influence hazard and risk approaches to the regulation of endocrine active substances |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215718/ https://www.ncbi.nlm.nih.gov/pubmed/27862884 http://dx.doi.org/10.1002/ieam.1866 |
work_keys_str_mv | AT parrottjoannel uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT bjerregaardpoul uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT bruggerkristine uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT graylearl uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT iguchitaisen uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT kadlecsarahm uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT weltjelennart uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances AT wheelerjamesr uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances |